In a major shift, the US Food and Drug Administration is relaxing a long-standing drug approval requirement for common ...

Neurodevelopmental outcomes seem similar for kids of moms who received and didn't receive a COVID-19 vaccine during or just before pregnancy.

President Trump has drawn criticism from some supporters for an executive order to increase production of the active ingredient in a common weedkiller.

An outspoken critic of the nation’s top public health agency has been tapped to lead it for the foreseeable future.

LA CAB for PrEP shows high effectiveness and persistence among Black cisgender and transgender women in the United States.

Real-world data show an ibalizumab-based regimen provides sustained virologic suppression in heavily treatment-experienced ...

Phase 3 trial results show BIC/LEN is noninferior to BIC/FTC/TAF for maintaining virologic suppression in adults with HIV.

Social and economic factors may drive COVID-19 hospitalization risk more than HIV status among reproductive-age women in the Southern US.

Switching to a once-daily fixed-dose combination of DOR/ISL maintains high rates of virologic suppression through 96 weeks in HIV-1.

Updated 2024-2025 COVID-19 vaccines significantly reduced the risk for hospitalization and severe outcomes despite the emergence of new viral lineages.

The Trump administration is pulling $600 million in CDC funding from California, Colorado, Illinois, and Minnesota to align ...

Research shows newborn hepatitis B vaccine refusal declined from 12.1% to 3.5%, although rates varied widely across different hospital systems.